No Firings, No Furloughs: FDA Staff Weathering COVID-19 Pandemic
Despite the challenges of teleworking due to the coronavirus pandemic, the US agency says it continues to fulfill its duties and has not had to let go of staff.
You may also be interested in...
The US FDA is collaborating with the Centers for Disease Control and Prevention to determine the best way for agency investigators to perform on-site inspections again, using the White House's "Guidelines for Opening Up America Again" for guidance. Routine surveillance audits were paused in the US and abroad back in March.
The tools include new laboratory methods, and computational models and simulations give the agency more capabilities to test and validate data in premarket submissions.
The US FDA’s latest report on non-regulated health and medical software finds they are not associated with any substantial increase in risks, though the agency admits there may be some underreporting.